Food News and Research

RSS

New skeletal tissue could revolutionize regenerative medicine and cartilage repair

An international research team led by the University of California, Irvine has discovered a new type of skeletal tissue that offers great potential for advancing regenerative medicine and tissue engineering.

9 Jan 2025

Can AI chatbots master the science of dietary balance?

Discover how AI chatbots are reshaping weight-loss planning with precision and variety, yet face challenges in balancing macronutrients for optimal health.

9 Jan 2025

Study questions accuracy of genetic test for opioid use disorder

Opioid misuse and specifically opioid use disorder (OUD), continues to represent a significant U.S. public health threat, with more than 6 million Americans aged 12 and older meeting the criteria for OUD in 2022.

9 Jan 2025

New antibiotic shows promise in fighting tuberculosis

A consortium including scientists from the Tropical Institute at LMU University Hospital has demonstrated the effectiveness of a new antibiotic.

9 Jan 2025

Study reveals widespread microplastic contamination in U.S. West Coast fish and shellfish

Researchers measure the levels of anthropogenic particles present in various seafood caught along the West Coat of the United States.

9 Jan 2025

Gut microbes and the body work together to regulate fat metabolism

Beneficial gut microbes and the body work together to fine-tune fat metabolism and cholesterol levels, according to a new preclinical study by investigators from Weill Cornell Medicine and the Boyce Thompson Institute at Cornell University's Ithaca campus.

9 Jan 2025

Could camembert cheese hold the key to better memory?

Myristamide enhances cognitive function and BDNF in mice, indicating Camembert cheese's potential in combating cognitive decline and supporting brain health.

9 Jan 2025

Time-restricted eating rivals Mediterranean diet but falls short for visceral fat loss

Time-restricted eating (TRE) is safe and feasible for weight management but offers no additional benefits over a Mediterranean diet for reducing visceral fat. Early TRE shows promise in reducing subcutaneous fat and improving fasting glucose levels.

8 Jan 2025

Carrots may offer natural support for people with type 2 diabetes

Could an ordinary carrot improve the treatment of type 2 diabetes? A new study from SDU suggests so.

8 Jan 2025

Can green tea help prevent cognitive decline?

Higher green tea consumption significantly reduces cerebral white matter lesions in older adults, offering potential protective effects against cognitive decline.

8 Jan 2025

Collaborative effort targets better nutrition for pregnant women and children

Poor nutrition during pregnancy can have serious consequences for both maternal and child health.

8 Jan 2025

New study identifies effective strategies to help people quit vaping

A new study, co-led by a University of Massachusetts Amherst researcher, set out to identify the most effective strategies for helping people quit vaping.

8 Jan 2025

Elderberry juice improves metabolic health and weight management

Elderberry juice may be a potent tool for weight management and enhancing metabolic health, according to a recent Washington State University-led study.

8 Jan 2025

Extreme weather impacts HIV prevention and treatment access

New challenges in HIV prevention and care are emerging due to climate change, according to a review published earlier this month in Current Opinions in Infectious Disease.

8 Jan 2025

University of Exeter launches new round of funding for fungal AMR solutions

A University of Exeter funding scheme designed to combat the global challenge of fungal antimicrobial resistance (fAMR) has announced a new call for applications.

8 Jan 2025

New research reframes the debate on drug development costs

The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications skewing public discussions about the cost of pharmaceutical research and development, according to a new RAND study.

8 Jan 2025

AI-designed drug shows promise for inflammatory bowel disease

Insilico Medicine ('Insilico'), a clinical-stage generative artificial intelligence (AI)-driven drug discovery and development company, today announces positive results from two Phase I studies in Australia and China of ISM5411, a novel gut-restricted and PHD specific Inhibitor designed and optimized with the support of Insilico's Chemistry42 commercially-available generative reinforcement learning platform, for Inflammatory Bowel Disease (IBD).

8 Jan 2025